Skip to main content

J&J Expects to Have 600-800 Million COVID-19 Vaccines by 2021

Author:
Video Duration:
0
Image placeholder title
Economics

J&J inks 2nd manufacturing deal to boost capacity for COVID-19 vaccine

Image placeholder title
Science

FDA Approves Saliva Based COVID-19 Test

Image placeholder title
Science

Former FDA Exec Says Pandemic Could End in 2021 With Pfizer and Moderna Vaccines

Image placeholder title
Science

Epidemiologist Says COVID-19 Is Increasing the Mental Health Crisis

Image placeholder title
Science

Researchers Develop Mask that Can Determine if Wearer Has COVID-19

Image placeholder title
Science

Researchers Believe a Hyperactive Immune System Might be Deadlier Than COVID-19

Image placeholder title
Science

Pfizer and BioNTech Vaccine Candidate is 90% Effective

Image placeholder title
Science

OSU Medical Center Scientists Create Solution Approved by FDA for COVID-19 Test

Image placeholder title
Science

Pfizer Plans to Submit Vaccine Candidate to FDA in Days